Introduction {#Sec1}
============

The increase in the incidence of skin cancers, combined with the advances in understanding the molecular biological mechanisms involved in tumour progression and interactions between melanoma cells and immune cells, has led to the development of several immune strategies for the treatment of these cancers (Dharmadhikari et al. [@CR25]). Among these strategies, the use of oncolytic virotherapies is emerging as an important approach in cancer treatment, due to their potential of inducing systemic anti-tumour immunity in addition to selectively killing cancer cells (Kaufman et al. [@CR57]; Fukuhara et al. [@CR39]; Filley and Dey [@CR36]). In spite of current expectations that oncolytic virus therapy will become in the future a standard therapy option for all cancer patients (Fukuhara et al. [@CR39]), there are still limitations of this therapy. The reduced effectiveness of the oncolytic viruses injected into cancer patients depends not only on the pathogenic nature of virally encoded genes, but also on the interactions between the virus and the host innate and adaptive immune responses (Melcher et al. [@CR74]; Kaufman et al. [@CR57]; Fukuhara et al. [@CR39]; Filley and Dey [@CR36]).

Macrophages are one of the key innate immune cells involved in the regulation of anti-cancer immunotherapies, having either immuno-stimulatory or immuno-suppresive effects (Allavena and Mantovani [@CR2]). These cells can display different phenotypes, in response to the type, concentration and longevity of exposure to stimulating agents (Cassetta et al. [@CR10]). The two extreme macrophages phenotypes are represented by the M1 and M2 cells; see (Mantovani et al. [@CR69]; Sica et al. [@CR90]; Allavena and Mantovani [@CR2]) and also Fig. [1](#Fig1){ref-type="fig"}. Note that this M1-M2 classification follows the Th1--Th2 ($\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD4}^{+}$$\end{document}$ T cells) classification, since the M1 cells are stimulated by Th1 cytokines, and M2 cells are stimulated by Th2 cytokines (Allavena and Mantovani [@CR2]). While it is accepted that the classically-activated M1 cells have anti-tumour properties and the alternatively-activated M2 cells have pro-tumour properties, many studies have shown that macrophages inside the tumour microenvironment have markers characterising mixed phenotypes (Mantovani and Sica [@CR68]; Allavena and Mantovani [@CR2]; Italiani and Boraschi [@CR53]). Because of the heterogeneity and plasticity of macrophages, it is very difficult to predict their impact on oncolytic virotherapies (Jakeman et al. [@CR54]; Denton et al. [@CR23]). For example, it has been shown experimentally that the M2 macrophages can support these therapies through the suppression of the anti-viral immune response (Denton et al. [@CR23]). The M1 macrophages may impede oncolytic therapies through the promotion of an anti-viral immune response that leads to viral clearance, but they also enhance the virus-mediated activation of the anti-tumour immune responses, which includes cells of the adaptive response such as $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells (Denton et al. [@CR23]).

In addition to the anti-viral innate immunity triggered by macrophages, as well as by other innate immune cells (e.g., neutrophils, natural killer (NK) cells; see Filley and Dey [@CR36]), oncolytic therapies can be impeded also by various adaptive immune responses (e.g., $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells; see Filley and Dey [@CR36]; Melcher et al. [@CR74]) and tumour/virus-induced cytokine production (e.g., IFN-$\documentclass[12pt]{minimal}
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                \begin{document}$$\gamma$$\end{document}$, TNF-$\documentclass[12pt]{minimal}
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                \begin{document}$$\alpha$$\end{document}$; see Filley and Dey [@CR36]), which can have direct anti-viral activities as well as immunoregulatory activities (Filley and Dey [@CR36]). These complex immune--virus interactions lead also to the development of the two main approaches on oncolytic therapies: the virocentric point of view (which sees the immune system as an obstacle to viral replication), and the immunocentric point of view (which focuses on the immunogenicity of the viruses and their roles in inducing effector immune responses that can eliminate disseminated tumour cells) (Alemany and Cascallo [@CR1]; Russell and Peng [@CR87]). To overcome the current limitations of virotherapies, which in most of the cases are applied to immunocompromised patients (Alemany and Cascallo [@CR1]; Russell and Peng [@CR87]), it is extremely important to investigate the complex interactions between oncolytic viruses and innate immunity (represented by pro-tumour/anti-tumour macrophages) as well as adaptive immunity (represented by $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells).Fig. 1**a** Classification of macrophages phenotypes, where cells are considered as part of a continuum, with the two extreme phenotypes of macrophages polarisation being represented by the classically activated M1 cells and the alternatively activated M2 cells. Tumour progression induces a $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {M1}\rightarrow \hbox {M2}$$\end{document}$ polarisation (Mantovani and Sica [@CR68]). Recent studies have also suggested a $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {Th1}\rightarrow \hbox {Th2}$$\end{document}$ polarisation during tumour progression \[see, for example, Fig. 5 in Tatsumi et al. ([@CR91])\]. **b** Caricature description of the interactions between tumour cells, innate immunity (described here by M1 and M2 cells), adaptive immunity (described here mainly by the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells), and oncolytic viruses. Oncolytic viruses can lead to the production of viral pathogen-associated molecular patterns (PAMPs) that can be presented on the surface of tumour cells or released in the microenvironment (Pol et al. [@CR83]), or danger-associated molecular patterns (DAMPs) that are released in the microenviromnent following virus-induced tumour lysis and which can promote macrophages activation (Martin [@CR71]). In this figure we show also the Th1 and Th2 $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD4}^{+}$$\end{document}$ T cells, which interact with the M1 and M2 cells generating type-I and type-II immune responses (Allavena and Mantovani [@CR2]; Mills [@CR76])

In this study, we focus on a highly metastatic cell line, B16F10 melanoma, which is also resistant against the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ cytotoxic T lymphocytes. Previous experimental studies with C57BL/6 mice have investigated the anti-tumour effects of $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells following the inoculation of Vesicular Stomatitis Virus (VSV) particles, which take advantage of the impaired interferon pathways in tumour cells (Hastie and Grdzelishvili [@CR47]). In addition, experimental studies have shown that melanoma tumours can contain up to 30% macrophages (Hussein [@CR51]), and hence the elucidation of the interaction mechanisms between macrophages and $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells is very important in the context of oncolytic therapies. Moreover, recent experimental results have emphasised the importance of macrophages on the motility and dissemination of murine melanoma cells (Roh-Johnson et al. [@CR85]). However, to the best of our knowledge, not many experimental studies have investigated in a quantitative manner (i.e., showing time-series experimental data) the complex pro-tumour/anti-tumour effects of various innate and adaptive immune cells in the tumour microenvironment, following the administration of an oncolytic virus (e.g., VSV).

To address this, in our paper we aim to investigate at a theoretical level (i.e., using mathematical and computational approaches, combined with different published experimental data), the interactions between the M1/M2 macrophages, the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells primed by the macrophages (although they can also be primed by the dendritic cells Pozzi et al. [@CR84]), and the VSV particles injected in a B16F10 tumour. To keep the model relatively simple, we will ignore other innate immune cells in the tumour microenvironment, such as dendritic cells (DCs) (Pozzi et al. [@CR84]), natural killer (NK) cells (Grundy et al. [@CR40]), which have also been associated with increased tumour elimination (Grundy et al. [@CR40]). We will also ignore the explicit dynamics of $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD4}^{+}$$\end{document}$ T helper cells, which have been shown to interact with the M1/M2 macrophages (Allavena and Mantovani [@CR2]) and with the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells (de Boer et al. [@CR20]) during anti-tumour and anti-viral immune responses; see also Fig. [1](#Fig1){ref-type="fig"}b. However, we need to emphasise that due to the mirroring of the M1 and Th1 immune responses, as well as the M2 and Th2 responses, even if we talk about M1 and M2 macrophages we think of \[as suggested in Mills ([@CR76])\] the more broad type-I immune responses (i.e., responses generated by M1 and Th1 cells) and type-II immune responses (i.e., responses generated by M2 and Th2 cells).

Mathematical and computational approaches have been widely used in the past to investigate the interactions between oncolytic viruses, tumour cells and immune cells (mainly cytotoxic T cells), with the overall aim of explaining existing observations or generating new testable hypotheses; see (Nowak and May [@CR77]; Wodarz [@CR96]; Wodarz and Komarova [@CR97]; Friedman et al. [@CR38]; Bajzer et al. [@CR4]; Dingli et al. [@CR28]; Paiva et al. [@CR80]; Komarova and Wodarz [@CR59]; Wu et al. [@CR99]; Eftimie et al. [@CR32]; Hofacre et al. [@CR50]; Rommelfanger et al. [@CR86]; Crivelli et al. [@CR17]; Macnamara and Eftimie [@CR65]; Kim et al. [@CR58]; Malinzi et al. [@CR66]; Eftimie et al. [@CR34]; Eftimie and Hamam [@CR30]) and the references therein. The majority of these models focus on the temporal evolution of viral titers and immune cell responses, thus being described by ordinary differential equations. Fewer models focus also on the spatial distribution of viruses inside solid tumours (Paiva et al. [@CR80]; Hofacre et al. [@CR50]; Malinzi et al. [@CR66]; Timalsina et al. [@CR93]; Malinzi et al. [@CR67]). Other mathematical models have been derived to investigate the role of M1 and M2 macrophages (and other innate immune cells) on tumour dynamics, including B10F16 melanoma (Louzoun et al. [@CR64]; den Breems and Eftimie [@CR21]; Eftimie and Hamam [@CR30]; Phan and Tian [@CR82]). A few other models investigated the anti-tumour effects of the interactions between innate and adaptive immune responses (Louzoun et al. [@CR64]; Eftimie et al. [@CR31]), and even fewer models focused on the effects of innate and adaptive immunity on oncolytic viral therapies (Timalsina et al. [@CR93]).

In the following, we use a mathematical approach to investigate the complex dynamics between the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells and M1 and M2 macrophages in the tumour microenvironment, with the overall aim of proposing new hypotheses regarding the mechanisms that could improve the anti-tumour effect of oncolytic viruses. In Sect. [2](#Sec2){ref-type="sec"}, we start with the experimental protocol introduced in Fernandez et al. ([@CR35]), where a Vesicular Stomatitis Virus (VSV) is injected into the system on two different days (days 10 and 13 after the inoculation of B16F10 melanoma cells), and use it to introduce a new mathematical model that quantifies the levels of virus infected/uninfected tumour cells, the levels of M1 and M2 macrophages, the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells which have been previously shown to infiltrate B16 murine melanoma, and the number of VSV particles. The model is parametrised using experimental data from Chen et al. ([@CR11]), Fernandez et al. ([@CR35]) (see also Fig. [2](#Fig2){ref-type="fig"}), and local sensitivity analysis is used to identify the parameters to which the tumour growth is most sensitive. We then use this model to investigate the anti-tumour effects of the oncolytic VSV, and how these effects interact with the anti-tumour immunity generated by the $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells and tumour-infiltrating macrophages. In particular, we aim to answer three main questions: (I) Can this mathematical model be used to test various hypotheses proposed in the experimental literature to reduce tumour burden? (II) How does macrophages plasticity affect the oncolytic virotherapies? (III) How does the balance between innate and adaptive immune responses impact the evolution of the tumour? We conclude in Sect. [4](#Sec9){ref-type="sec"} with a summary of the results and a discussion on data availability and model complexity.

Model Description {#Sec2}
=================

To investigate the effect of M1 and M2 macrophages on the anti-tumour oncolytic therapy with VSV and the interactions between macrophages and cytotoxic T cells, we consider a mathematical model that describes the time evolution of the following variables: the density of uninfected tumour cells ($\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {u}}$$\end{document}$), the density of virus-infected tumour cells ($\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {i}}$$\end{document}$), the density of virus particles ($\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {v}}$$\end{document}$), the density of M1 macrophages ($\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {m1}}$$\end{document}$), the density of M2 macrophages ($\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {m2}}$$\end{document}$) and the density of cytotoxic (effector) $\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {e}}$$\end{document}$); see also Fig. [1](#Fig1){ref-type="fig"}b. The time-evolution of these densities is described by the following equations: $$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} \frac{dx_{\text {v}}}{dt}\,=\,&H(t)+\delta _{i} b x_{\text {i}} -\omega x_{\text {v}} -d_{u}^{v}x_{\text {v}}\frac{x_{\text {e}}}{h_{e}+x_{\text {e}}} -d_{m1}^{v}x_{\text {v}}\frac{x_{\text {m1}}}{h_{m}+x_{\text {m2}}}, \end{aligned}$$\end{document}$$$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} \frac{dx_{\text {m2}}}{dt}\,=\,&a_{2}^{u}x_{\text {u}}+p_{m2}x_{\text {m2}}\left (1-\frac{x_{\text {m1}}+x_{\text {m2}}}{M} \right )+x_{\text {m1}}\left (r_{m1}^{0}+r_{m1}^{u}\frac{x_{\text {u}}}{h_{u}+x_{\text {u}}}\right) \\ & -x_{\text {m2}}\left ( r_{m2}^{0} +r_{m2}^{v}\frac{x_{\text {v}}}{h_{v}+x_{\text {v}}}\right ) -d_{em2}x_{\text {m2}}, \end{aligned}$$\end{document}$$$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\begin{aligned} \frac{dx_{\text {e}}}{dt}=&p_{e}\frac{x_{\text {m1}}}{h_{m}+x_{\text {m2}} }-d_{ee}x_{\text {e}}-d_{t}x_{\text {u}}x_{\text {e}}. \end{aligned}$$\end{document}$$ These equations incorporate the following biological assumptions:The uninfected tumour cells, described by Eq. ([1a](#Equ1){ref-type=""}), proliferate logistically with rate *r*, up to a carrying capacity *K*. Here, we assume a logistic growth because various experimental studies showed evidence of a reduced rate of tumour growth at larger sizes; see, for example, Laird ([@CR62]), Looney et al. ([@CR63]), Guiot et al. ([@CR42]). Further, we assume that the virus particles infect, at a rate $\documentclass[12pt]{minimal}
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                \begin{document}$$d_{v}$$\end{document}$, only a certain proportion of the tumour (due to a multitude of obstacles associated with the tumour microenvironment  Wong et al. [@CR98]). This can be modelled using a saturated term for the tumour--virus interactions, with $\documentclass[12pt]{minimal}
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                \begin{document}$$h_{u}^{v}$$\end{document}$ the half saturation constant for tumour cells infected with the oncolytic virus particles. The uninfected tumour cells can be eliminated at a rate $\documentclass[12pt]{minimal}
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                \begin{document}$$d_{u}$$\end{document}$ by IFN$\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells. Note that the saturated term in ([1a](#Equ1){ref-type=""}) for tumour elimination by $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells describes the fact that only a fraction of these cells are IFN$\documentclass[12pt]{minimal}
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                \begin{document}$$\gamma$$\end{document}$ positive---see also (Bridle et al. [@CR8]). Moreover, we assume that the uninfected tumour cells can be eliminated by the M1 cells at a rate $\documentclass[12pt]{minimal}
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                \begin{document}$$d_{m1}$$\end{document}$, since high numbers of infiltrating M1 macrophages are associated with good patient prognosis (Mantovani et al. [@CR70]), and can eliminate mouse melanoma even in the absence of $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells (Hara et al. [@CR45]). The presence of M2 cells inhibits the anti-tumour immune response generated by these M1 cells (Sica et al. [@CR90]). Finally, we assume that these M2 cells support tumour growth at a rate $\documentclass[12pt]{minimal}
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                \begin{document}$$d_{m2}$$\end{document}$, through the pro-tumour cytokines they secrete (Allavena and Mantovani [@CR2]).The virus-infected tumour cells, described by Eq. ([1b](#Equ2){ref-type=""}), die at a rate $\documentclass[12pt]{minimal}
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                \begin{document}$$\delta _{i}$$\end{document}$ following viral replication and cell burst (see Eq. ([1c](#Equ3){ref-type=""})). The infected cells can be detected and eliminated at a rate $\documentclass[12pt]{minimal}
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                \begin{document}$$\gg d_{m1}$$\end{document}$) by the M1 macrophages (Hashimoto et al. [@CR46]; Italiani and Boraschi [@CR53]), or at a rate $\documentclass[12pt]{minimal}
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Remark 1 {#FPar1}
--------

Many mathematical models in the literature assume linear interactions between different components of the system; see, for example, (Dingli et al. [@CR28]; Kim et al. [@CR58]; Eftimie and Hamam [@CR30]; den Breems and Eftimie [@CR21]). While these assumptions simplify the analysis of the models, they might not always be realistic since many biological interactions occur in a saturated-like manner and thus can be phenomenologically described by saturated functions of the form $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\frac{x}{c+x}$$\end{document}$ (where *x* is the variable under consideration, and *c* is a constant). As an example, experimental data in Dudley et al. ([@CR29]) showed that the percentage lysis of tumour cells by cytotoxic immune cells is saturated (with very large numbers of immune effector cells not leading to more effective tumour killing). Neither the tumour--virus interactions could always be described by linear interactions, since it would mean that larger numbers of oncolytic viruses would always kill the tumour. Experimental studies in Choi et al. ([@CR12]) with an oncolytic parapoxvirus showed that while virus levels of $\documentclass[12pt]{minimal}
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                \begin{document}$$10^{5}$$\end{document}$ PFU per tumour all lead to tumour reduction, the differences in tumour sizes were not always very significant--- especially in later days (suggesting a sort of saturated effect). Regarding the VSV effects on B16F10 melanoma, the majority of studies in the literature focus on the percentage survival of mice. A different approach was shown in Bridle et al. ([@CR7]), where the authors investigated experimentally the effect of a fixed VSV level (i.e., $\documentclass[12pt]{minimal}
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Parameter Approximation {#Sec3}
-----------------------

Fig. 2**a** (i) Growth of B16F10 tumour cells and (ii) the re-polarisation of M1 and M2 macrophages, as described by data re-drawn from Chen et al. ([@CR11]). Here the authors injected mice with $\documentclass[12pt]{minimal}
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To investigate the dynamics of tumour--immune--virus system ([1](#Equ1){ref-type=""}), we first need to approximate the values of the parameters. In the following we discuss the approaches taken to identify the parameter values associated with tumour dynamics alone, the parameter values for the tumour--immune interactions, and the parameter values associated with the virus dynamics. All these values are summarised in Table [1](#Tab1){ref-type="table"}.

Nevertheless, before we discuss these approaches, we need to emphasise that in mathematical and computational immunology, many researchers have used parameters already published in the literature: either measured experimentally following some particular experimental in vivo and/or in vitro studies, or parameters taken from other published mathematical and computational models (de Boer and Perelson [@CR19]; Eftimie et al. [@CR33]). This is a significant problem, since very few labs measure and estimate kinetics parameters, and even in this case the parameters are estimated for specific systems and might differ between studies (depending on the estimation method used, on the cell lines and virus strains used in the experiments, etc.) (de Boer and Perelson [@CR19]; Eftimie et al. [@CR33]). The only rigorous approach of dealing with this problem---which is both expensive and time consuming, but could lead to results that might have predictive power---is to estimate experimentally all parameters that appear in a model. In this study, we do not follow this rigorous approach, but rather follow the approaches taken by the majority of studies in the literature. To this end, we take some parameter values from the published immunological and mathematical literature (e.g., the in vitro proliferation rates of B16F10 murine cells (Danciu et al. [@CR18]), the carrying capacity of macrophages (Eftimie and Hamam [@CR30]), or the baseline M1$\documentclass[12pt]{minimal}
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Results {#Sec4}
=======

In the following we start the investigation into the role of macrophages on oncolytic virotherapies by performing first a local sensitivity analysis, to identify those parameters to which the model is most sensitive and to see which of these parameters are important in macrophages polarisation. Then we focus on a few virus-related and immune-related parameters (some identified as important during the sensitivity analysis), which will be varied to reproduce different experimental and clinical approaches aimed at controlling tumour growth. In this context, we will discuss the effect of varying these parameters on the size of M1 and M2 populations, and how this correlates with tumour control/elimination. This investigation will address mainly question (I) from the Introduction. To address questions (II) and (III) we will combine numerical simulations for transient system dynamics with steady-state analysis of long-term dynamics.

Sensitivity Analysis {#Sec5}
--------------------

Before investigating the transient and long-term dynamics of model ([1](#Equ1){ref-type=""}), we perform a local sensitivity analysis to obtain a first understanding on the importance of anti-tumour viral responses (i.e., virocentric perspective) versus anti-tumour immune responses (i.e., immunocentric perspective). Since we are interested in identifying the parameters that can slow down tumour relapse, we investigate the relative changes in tumour size on day $\documentclass[12pt]{minimal}
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Overall, these sensitivity results emphasise the importance of both innate and adaptive immunity on tumour relapse, thus supporting the immunocentric point of view (Alemany and Cascallo [@CR1]). Another aspect emphasised by these sensitivity results is that even small changes in these immune-related parameters (due to environmental heterogeneity and stochasticity Satija and Shalek [@CR89]; Jiménez-Sánchez et al. [@CR55]; Papalexi and Satija [@CR81]) could affect significantly the outcome of the oncolytic viral therapy and the survival of the patient.

### Remark 2 {#FPar2}

We have also investigated (not shown here) tumour sensitivity to the rate at which the $\documentclass[12pt]{minimal}
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In the following we use model ([1](#Equ1){ref-type=""}) to investigate different immunological hypotheses associated with changes in the parameters to which the tumour is most sensitive.

Baseline Model Dynamics {#Sec6}
-----------------------

We start the investigation into the dynamics of model ([1](#Equ1){ref-type=""}) by showing in Fig. [4](#Fig4){ref-type="fig"}(a) the baseline dynamics when the VSV is injected on days $\documentclass[12pt]{minimal}
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Next, we move away from the experimental studies in Fernandez et al. ([@CR35]), Chen et al. ([@CR11]) and investigate whether model ([1](#Equ1){ref-type=""}) can reproduce various anti-tumour treatment approaches proposed by different experimental studies. The parameters that we will vary in this context, which can be controlled experimentally, will help us further propose hypotheses regarding the best approaches for tumour control/elimination.

Changes in Virus-Related and Immune-Related Parameters {#Sec7}
------------------------------------------------------

*Changes in virus-induced macrophages re-polarisation rate*$\documentclass[12pt]{minimal}
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*Changes in tumour-induced macrophages re-polarisation rate*$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$r_{m1}^{u}$$\end{document}$. Over the past few years, various experimental and clinical studies focused on preventing the differentiation of M2 macrophages for better anti-tumour outcomes (e.g., by depriving the tumour of growth factors and thus preventing the M1$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\rightarrow$$\end{document}$M2 differentiation; see the review in Heusinkveld and van der Burg ([@CR48]) or the clinical study in Coward et al. ([@CR16])). To investigate this treatment approach, next we study computationally the effect of decreasing parameter $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$r_{m1}^{u}$$\end{document}$ which controls this tumour-induced M1$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\rightarrow$$\end{document}$M2 differentiation. Figure [6](#Fig6){ref-type="fig"}b shows that a significant decrease in the re-polarisation rate $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$r_{m1}^{u}$$\end{document}$ can lead to tumour control (and even elimination; e.g. for $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$r_{m1}^{u}=1$$\end{document}$, not shown here). Here, tumour control is the result of a relatively large $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cell population, which seems to dominate the immune response for $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$t\in (15,25)$$\end{document}$, and a very large M1:M2 ratio (although the macrophages population as a whole, M1+M2, is quite low). The VSV level is relatively low, as the anti-tumour and anti-viral immune responses control the dynamics of the system. These numerical results are consistent with some experimental studies showing the activation of $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells following the administration of VSV (Bridle et al. [@CR7]). However, the tumour relapse triggered by the increase in the total number of macrophages (as well as the M2:M1 ratio), suggests the necessity of tracking experimentally not only the T cells' response to VSV \[as done in Bridle et al. ([@CR7])\], but also the interactions between T cells and macrophages.

Overall, Figs. [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"} suggest that there are two mechanisms through which the tumour is kept under control and even eliminated: a viral-dominated response (as in Fig. [6](#Fig6){ref-type="fig"}a) and an immune-dominated response (as in Fig.  [5](#Fig5){ref-type="fig"}b). We need to emphasise that the viral-dominated anti-tumour response generates quickly a very strong immune response that ensures persistent tumour elimination. This kind of dynamics might lead to a confusion as to whether the tumour is eliminated by the immune response or by the viral replication. We stress that these two mechanisms (virocentric vs. immunocentric) depend on the model parameters, which can be different for different cells inside the same patient (as shown by a recent clinical study on the heterogeneity of tumour--immune microenvironments; see Jiménez-Sánchez et al. [@CR55]).Fig. 7Dynamics of model ([1](#Equ1){ref-type=""}) as we increase the following parameters: **a**$\documentclass[12pt]{minimal}
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We note here that varying other immune parameters to which the tumour is sensitive---see Fig. [3](#Fig3){ref-type="fig"}---leads to a model dynamics similar to the one shown in Fig. [7](#Fig7){ref-type="fig"}. Moreover, we believe that using other sets of parameters that could fit the data in Chen et al. ([@CR11]) and Fernandez et al. ([@CR35]) would likely lead to tumour-immune-virus dynamics similar to the cases shown in Figs. [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"} and [7](#Fig7){ref-type="fig"}.Fig. 8**a** Tumour-free steady state ($\documentclass[12pt]{minimal}
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Long-term Dynamics: Steady States and Their Stability {#Sec8}
-----------------------------------------------------

The numerical simulations presented in the previous sections suggested the possibility of having long-term behaviours characterised by tumour elimination and the persistence of an immune response, or behaviours characterised by the coexistence of tumour and immune cells. In the following we aim to obtain a better understanding of these behaviours by focusing on the steady states $\documentclass[12pt]{minimal}
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Summary and Discussion {#Sec9}
======================

In this study we introduced a mathematical model for the investigation of the interactions between melanoma tumour cells, an oncolytic Vesicular Stomatitis Virus (VSV) that was administered twice in 3 days, and innate and adaptive immune responses. We first parametrised the model without the oncolytic virus by fitting it to baseline experimental data in Chen et al. ([@CR11]), which focused on the anti-tumour/pro-tumour immune response of the M1 and M2 macrophages. Then, we fixed the tumour and immune-related parameters, and fit the full model with the oncolytic virus (VSV) to the baseline experimental data in Fernandez et al. ([@CR35]). To ensure a better model-to-data fit, we incorporated the assumption of higher anti-tumour immune responses following the first viral infection, which leads to the release of TAAs, PAMPs and DAMPs by destroyed tumour cells. For the parameters shown in Table [1](#Tab1){ref-type="table"}, the anti-tumour immune responses following the VSV injection ($\documentclass[12pt]{minimal}
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                \begin{document}$$d_{m1}^{t>11}$$\end{document}$) depends on the multitude of fixed tumour and immune parameters (identified through fitting the data in Chen et al. ([@CR11])), and since it is likely that one can find multiple sets of tumour and immune parameters that can fit the data in Chen et al. ([@CR11]), we expect that it is possible to find also lower immune responses that fit the data in Fernandez et al. ([@CR35]). However, this sort of parameter investigation was not the aim of this current study. Rather, our goal was to investigate whether we can use only one class of mathematical models to reproduce and explain the dynamics suggested by data generated by two different experimental systems, and to further investigate the overall model dynamics. A global parameter optimisation, which can be used to fit at the same time multiple different experiments, will be the subject of a different study. We should emphasise here that despite the possibility of having different sets of parameter values that fit the same data, we would not expect significant changes in the overall dynamics of the system ([1](#Equ1){ref-type=""}) - see also Figs. [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}.

Using the model derived in this study we then investigated the different tumour-immune-virus dynamics exhibited by model ([1](#Equ1){ref-type=""}). Thus, through simulations we identified two types of anti-tumour responses, a viral-dominated response and an immune-dominated response (see Fig. [6](#Fig6){ref-type="fig"}), which can coexist in the same system and are dependent on different model parameters. Note that the increased viral oncolysis, which leads to tumour elimination in Fig. [6](#Fig6){ref-type="fig"}, seems to be immediately followed by an increased anti-tumour immune response that ensures persistent tumour elimination. Despite the numerically identified virus-induced tumour elimination observed in Fig. [6](#Fig6){ref-type="fig"}a(i) for large $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells and M1 cells levels, thus ensuring that tumour elimination persists for long periods of time. In regard to the anti-tumour immunity following the injection of oncolytic viruses, we have seen in Fig. [5](#Fig5){ref-type="fig"}b that multiple VSV injections could eliminate a tumour that is otherwise kept under control by the immune system. One should be aware that larger doses of VSV could have neurotoxic effects (Bridle et al. [@CR7]). Therefore, while multiple VSV injections could lead to better anti-tumour outcomes, one needs to investigate also the optimal level of VSV that is therapeutically safe for the patients.

In the context of question (II) from the Introduction, we showed in Fig. [11](#Fig11){ref-type="fig"} that the macrophages' plasticity (as quantified by *c*) did not seem to have a big impact on small and large tumours, but might have some impact on medium-size tumours, i.e., tumours around the detection threshold ($\documentclass[12pt]{minimal}
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*Simplicity vs. complexity in mathematical immunology* The complexity of the immune response, and in particular the tumour--immune interactions in the context of macrophages plasticity with multiple cell phenotypes, could lead us to think that incorporating more details into the mathematical models might shed light on the specific aspects of the immune responses that could control tumour growth. For example, one could think that understanding the detailed interactions between the adaptive and innate immunity, or the different aspects of innate immunity, or the saturated vs. linear interactions between tumour cells, immune cells and/or virus particles, might help us find the mechanisms that could control tumour growth. While these specific details could indeed help us investigate (mostly numerically) their role on the overall dynamics of the model, the complexity of the new models that contain large numbers of equations/terms makes them very difficult to be investigated analytically (see [Appendix](#Sec10){ref-type="sec"}), to draw general conclusions about the importance of specific sets of parameters on tumour control. Moreover, the new models have very large parameter spaces (even after non-dimensionalisation---not shown for this study). Sensitivity analysis could be used to identify the parameters that are most likely to influence model dynamics, but the results are dependent on the baseline parameter values/ranges (obtained through model parametrisation or just guessed).

As shown in Fig. [1](#Fig1){ref-type="fig"}, we could have included in system ([1](#Equ1){ref-type=""}) also a Th1--Th2 adaptive immune response (which mirrors the M1-M2 macrophages response), but the model would have been even more complex, and even less informative. Or we could have incorporated other immune cells, such as the NK cells that support oncolytic virotherapies (Diaz et al. [@CR26]; Bhat and Rommelaere [@CR6]).

In the context of visualising the behaviour of our tumour-immune-virus system, we need to emphasise that the large number of equations in model ([1](#Equ1){ref-type=""}), which underlines the complexity of this model, can lead to some difficulties regarding the calculation of the steady states and their visualisation. In Figs. [8](#Fig8){ref-type="fig"}, [9](#Fig9){ref-type="fig"} we graph in 3D two of the simpler steady states exhibited by model ([1](#Equ1){ref-type=""}), as we vary some model parameters. While the 3D-plots are not always very helpful, they might be necessary for a basic understanding of the behaviour of complex models---as shown in Sect. [3.4](#Sec8){ref-type="sec"}.

We conclude this discussion by emphasising that such complex mathematical models can only be used to qualitatively investigate the possible dynamics of the system. Moreover, we emphasise that one should strive for simplicity in modelling, as long as the model incorporates all the predominant elements/variables required to answer specific biological questions, and as long as the model can be fitted to available data.

*Model parametrisation* In the published literature, there is very little immunological data that can be used to parametrise mathematical models. The majority of published experimental papers show time series of tumour growth, with extremely few papers showing time series of various immune responses. Moreover, when both such time series can be found, those for the tumour growth are not always obtained under the same conditions (i.e., the same mouse line, the same treatment, etc.), as the time series for the immune responses. To parametrise (relatively complex) mathematical models for tumour--immune interactions, one option is to use multiple data sets obtained in different experimental settings and to further investigate model sensitivity to the identified parameters. In this study we used two different data sets from Fernandez et al. ([@CR35]), Chen et al. ([@CR11]) where, for consistency, we focused exclusively on the baseline control tumour data (i.e., B16F10 melanoma data obtained in the absence of any external treatment) and macrophages immune data in C57BL/6 mice. However, we should have also parametrised the model using VSV decay data and $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {CD8}^{+}$$\end{document}$ T cells data---but we could not find such data. Note that this type of model parametrisation using multiple data sets is somehow similar to the use of parameters taken from various published studies (a very common practice in mathematical immunology, but which leads to more variation in parameter values).

Therefore, for a mathematical model to provide quantitative results that could be used to make predictions which could further inform experiments, it is necessary to parametrise it using sufficient data. Thus more close collaborations between mathematical modellers and experimentalists are necessary to move this field forward.

Appendix A: Linear Stability of Steady States {#Sec10}
=============================================

The linear stability of the steady states $\documentclass[12pt]{minimal}
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                \begin{document}$$(x_{\text {u}},x_{\text {i}},x_{\text {v}},x_{\text {m1}},x_{\text {m2}},x_{\text {e}})$$\end{document}$ is given by the eigenvalues of the Jacobian matrix (*J*) associated with system ([1](#Equ1){ref-type=""}):$$\documentclass[12pt]{minimal}
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                \begin{document}$$a_{i,j}$$\end{document}$ the terms obtained after differentiating the right-hand-sides of Eq. ([1](#Equ1){ref-type=""}) with respect to the model variables.
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                \begin{document}$$(0,0,0,x^{*}_{\text {m1}},x^{*}_{\text {m2}},x^{*}_{\text {e}})$$\end{document}$, we obtain $\documentclass[12pt]{minimal}
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                \begin{document}$$a_{31}=a_{34}=a_{35}=a_{36}=0$$\end{document}$. By writing down the non-zero terms in this Jacobian matrix one can easily observe that $\documentclass[12pt]{minimal}
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                \begin{document}$$\det (J-\lambda \mathbb {I}_{6})=0$$\end{document}$ (with $\documentclass[12pt]{minimal}
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                \begin{document}$$6\times 6$$\end{document}$ identity matrix) has the following eigenvalues:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\lambda _{1}<0$$\end{document}$ (see Equation ([3](#Equ9){ref-type=""})). The other two eigenvalues ($\documentclass[12pt]{minimal}
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                \begin{document}$$\lambda _{4,5}$$\end{document}$) are given by the roots of a quadratic:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} \lambda _{4,5}=\frac{1}{2}\left ( A\pm \sqrt{A^{2}-4B} \right ), \end{aligned}$$\end{document}$$where$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} A=-p_{m}+d_{em}-(r_{m1}^{0}+r_{m2}^{0})<0 \;\;\text {since}\;\; p_{m}>d_{em} \;\; (\text {for} \; x^{*}_{\text {m}}\; \text {to exist}), \end{aligned}$$\end{document}$$and$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} B= & {} \Big [ p_{m}\Big (1-\frac{x^{*}_{\text {m}}}{M}\Big )-d_{em} \Big ]^{2} - \Big [p_{m}\Big (1-\frac{x^{*}_{\text {m}}}{M}\Big )-d_{em} \Big ]\Big [p_{m}\frac{x^{*}_{\text {m}}}{M}+r_{m1}^{0}+r_{m2}^{0} \Big ] \\&+\frac{p_{m}x^{*}_{\text {m}}}{M}(r_{m1}^{0}+r_{m2}^{0}). \end{aligned}$$\end{document}$$We note that $\documentclass[12pt]{minimal}
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                \begin{document}$$p_{m}(1-\frac{x_{\text {m}}^{*}}{M})-d_{em}=0$$\end{document}$ (from the definition of $\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {m}}^{*}$$\end{document}$; see Eq. ([2b](#Equ8){ref-type=""})). Since $\documentclass[12pt]{minimal}
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                \begin{document}$$\lambda _{4,5}<0$$\end{document}$. Therefore, the stability of the tumour-free state is given exclusively by the sign of $\documentclass[12pt]{minimal}
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                \begin{document}$$\lambda _{1}$$\end{document}$, as requested by Equation ([3](#Equ9){ref-type=""}).

Remark 3 {#FPar3}
--------

Note that to calculate the tumour-free virus-free steady state $\documentclass[12pt]{minimal}
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                \begin{document}$$(0,0,0,x_{\text {m1}}^{*},x_{\text {m2}}^{*},x_{\text {e}}^{*})$$\end{document}$ given by Equations (2), we used the steady-state Equation ([1f](#Equ6){ref-type=""}) to obtain $\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {e}}^{*}$$\end{document}$, and the steady-state Equations ([1d](#Equ4){ref-type=""}) and ([1e](#Equ5){ref-type=""}) (in which we substituted the expression for $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
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                \begin{document}$$x_{\text {m}}^{*}$$\end{document}$ satisfying ([2b](#Equ8){ref-type=""})) to obtain $\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {m2}}^{*}$$\end{document}$. For example,$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} (1d)\Rightarrow\, & {} 0=x_{\text {m1}}^{*}\Big (p_{m}\big (1-\frac{x_{\text {m}}^{*}}{M} \big )-d_{em} \Big )-x_{\text {m1}}^{*}r_{m1}^{0}+(x_{\text {m}}^{*}-x_{\text {m1}}^{*})r_{m2}^{0}\\\Leftrightarrow\, & {} 0=x_{\text {m1}}^{*}\underbrace{\Big (0\Big )}_{Eq.(2b)}-x_{\text {m1}}^{*}r_{m1}^{0}+(x_{\text {m}}^{*}-x_{\text {m1}}^{*})r_{m2}^{0} \\\Rightarrow\, & {} x_{\text {m1}}^{*}=\frac{x_{\text {m}}^{*} r_{m2}^{0}}{r_{m1}^{0}+r_{m2}^{0}}. \end{aligned}$$\end{document}$$In a similar manner one can use the steady state Equation ([1e](#Equ5){ref-type=""}) to obtain the expression for $\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {m2}}^{*}$$\end{document}$.
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                \begin{document}$$(x_{\text {u}}^{*},0,0,x^{*}_{\text {m1}},x^{*}_{\text {m2}},x^{*}_{\text {e}})$$\end{document}$, given implicitly by Eq. (4), we obtain $\documentclass[12pt]{minimal}
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                \begin{document}$$a_{31}=a_{34}=a_{35}=a_{36}=0$$\end{document}$. The eigenvalues $\documentclass[12pt]{minimal}
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                \begin{document}$$\lambda$$\end{document}$ of the Jacobian matrix satisfy a 6th-order polynomial, which cannot be solved explicitly (to identify the combinations of parameters that control the stability of the steady states). Moreover, as we can see in Fig. [9](#Fig9){ref-type="fig"}, for fixed parameter values there seem to be an infinite number of possible steady states.

The coefficient terms in this 6th-order polynomial are even more complicated if we consider the tumour-present virus-present immune-present states $\documentclass[12pt]{minimal}
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                \begin{document}$$(x_{\text {u}},x_{\text {i}},x_{\text {v}},x_{\text {m1}},x_{\text {m2}},x_{\text {e}})$$\end{document}$. Therefore, the complexity of the model (and in particular the presence of nonlinear saturated terms) renders almost impossible the classical linear stability analysis (although stability can be calculated numerically for specific parameter values, as shown in Fig. [10](#Fig10){ref-type="fig"}).

Remark 4 {#FPar4}
--------

Not only that we cannot investigate the stability of the tumour-present virus-present immune-present steady stats, but even finding closed-form equations for these states is challenging. To obtain the implicit Eqs. ([6](#Equ13){ref-type=""})--([7](#Equ14){ref-type=""}) that describe these states, we started with Equation ([1f](#Equ6){ref-type=""}) from which we obtained$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} \frac{x_{\text {m1}}^{*}}{h_{m}+x_{\text {m2}}^{*}}=\frac{x_{\text {e}}^{*}}{p_{e}}\big (d_{ee}-d_{t}x_{\text {u}}^{*} \big ) \end{aligned}$$\end{document}$$Then, adding ([1b](#Equ2){ref-type=""})+([1c](#Equ3){ref-type=""}) in which we substitute the above expression leads to$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} d_{v}x_{\text {v}}^{*}\frac{x_{\text {u}}^{*}}{h_{u}^{v}+x_{\text {u}}^{*}}=-\delta _{i}x_{\text {i}}^{*}(b-1)-(x_{\text {i}}^{*}+x_{\text {v}}^{*})\Big (d_{u}^{v}\frac{x_{\text {e}}^{*}}{h_{e}+x_{\text {e}}^{*}}-d_{m1}^{v}\frac{x_{\text {e}}^{*}}{p_{e}}(d_{ee}-d_{t}x_{\text {u}}^{*}) \Big ). \end{aligned}$$\end{document}$$For $\documentclass[12pt]{minimal}
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                \begin{document}$$b=1$$\end{document}$ the first term on the right-hand-side vanishes. If $\documentclass[12pt]{minimal}
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                \begin{document}$$C_{0}$$\end{document}$.

If we now focus on the steady-state Eq. ([1a](#Equ1){ref-type=""}), and solve for the same term $\documentclass[12pt]{minimal}
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                \begin{document}$$d_{v}x_{\text {v}}^{*}x_{\text {u}}^{*}/(h_{u}^{v}+x_{\text {u}}^{*})$$\end{document}$ while denoting by $\documentclass[12pt]{minimal}
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                \begin{document}$$c=x_{\text {m2}}^{*}/(h_{m}+x_{\text {m2}}^{*})\in (0,1)$$\end{document}$, we obtain :$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} d_{v}x_{\text {v}}^{*}\frac{x_{\text {u}}^{*}}{h_{u}^{v}+x_{\text {u}}^{*}}=rx_{\text {u}}^{*}\Big (1-\frac{x_{\text {u}}^{*}}{K} \Big )-d_{u}x_{\text {u}}^{*}\frac{x_{\text {e}}^{*}}{h_{e}+x_{\text {e}}^{*}}-d_{m1}x_{\text {u}}^{*}\frac{x_{\text {e}}^{*}}{p_{e}}(d_{ee}-d_{t}x_{\text {u}}^{*})+d_{m2}x_{\text {u}}^{*}c. \end{aligned}$$\end{document}$$Equating ([9](#Equ16){ref-type=""}) and ([10](#Equ17){ref-type=""}) leads to the following equation (which combines ([1a](#Equ1){ref-type=""}), ([1b](#Equ2){ref-type=""}), ([1c](#Equ3){ref-type=""}) and ([1f](#Equ6){ref-type=""})):$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned}&(x_{\text {i}}^{*}+x_{\text {v}}^{*})\Big [d_{u}^{v}\frac{x_{\text {e}}^{*}}{h_{e}+x_{\text {e}}^{*}}-d_{m1}^{v}\frac{x_{\text {e}}^{*}}{p_{e}} (d_{ee}-d_{t}x_{\text {u}}^{*}) \Big ]=rx_{\text {u}}^{*}\Big (1-\frac{x_{\text {u}}^{*}}{K} \Big )-d_{u}x_{\text {u}}^{*}\frac{x_{\text {e}}^{*}}{h_{e}+x_{\text {e}}^{*}} \\&\quad -d_{m1}x_{\text {u}}^{*}\frac{x_{\text {e}}^{*}}{p_{e}}(d_{ee}-d_{t}x_{\text {u}}^{*})+d_{m2}x_{\text {u}}^{*}c+C_{0}. \end{aligned}$$\end{document}$$On the other hand, combining the steady-state Eqs. ([1d](#Equ4){ref-type=""}) and ([1e](#Equ5){ref-type=""}) leads to$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} (x_{\text {i}}^{*}+x_{\text {v}}^{*})=\frac{1}{a_{1}^{v}}\Big [-x_{\text {u}}^{*}(a_{1}^{u}+a_{2}^{u})-x_{\text {m}}^{*}\big (p_{m}-d_{em}-\frac{p_{m}}{M}x_{\text {m}}^{*} \big ) \Big ]. \end{aligned}$$\end{document}$$Substituting ([12](#Equ19){ref-type=""}) into ([11](#Equ18){ref-type=""}) leads to Equation ([6](#Equ13){ref-type=""}).

To obtain ([7](#Equ14){ref-type=""}), we eliminate the similar terms in ([1b](#Equ2){ref-type=""}) and ([1c](#Equ3){ref-type=""}) that contain $\documentclass[12pt]{minimal}
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                \begin{document}$$d_{u}^{v}x_{\text {e}}^{*}/(h_{e}+x_{\text {e}}^{*})+d_{m1}^{v}x_{\text {m1}}^{*}/(h_{m}+x_{\text {m2}}^{*})$$\end{document}$. This leads to$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} d_{v}\frac{x_{\text {v}}^{*}}{x_{\text {i}}^{*}}\frac{x_{\text {u}}^{*}}{h_{u}^{v}+x_{\text {u}}^{*}}-\delta _{i}=\delta _{i}b \frac{x_{\text {i}}^{*}}{x_{\text {v}}^{*}}-\omega . \end{aligned}$$\end{document}$$Denoting by $\documentclass[12pt]{minimal}
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                \begin{document}$$x_{\text {vi}}^{*}:=x_{\text {v}}^{*}/x_{\text {i}}^{*}$$\end{document}$, the above equation reduces to ([7](#Equ14){ref-type=""}).
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